Strategic partnerships within the biopharmaceutical industry are key to accelerating the process of getting medicines to patients. I recently sat down with Pallavi Garg, Head of the U.S. Oncology Business Unit at Takeda, to explore how collaboration in our industry is driving progress in the fight against cancer.
Our discussion highlights how Takeda’s partnerships are not just addressing unmet needs in oncology, but also breaking down barriers to innovation. These efforts align with our industry’s goal: ensuring groundbreaking medicines reach patients when they need them most.
Watch the video to learn more about Takeda’s patient-centric approach to shaping the future of oncology research.
Since recording this video, Pallavi’s role has shifted to Head of the U.S. Oncology Business Unit at Takeda.
Lori M. Reilly, Esq.
Lori M. Reilly is chief operating officer at PhRMA, providing executive level management, leadership and strategic direction for the organization. In this role, Reilly oversees PhRMA’s advocacy activities, including its federal, state and international government affairs and alliance development work. Reilly provides strategic leadership and works across PhRMA to develop and advocate for practical policy solutions that will lower costs for patients.
Reilly, named by the Washingtonian as one of the 250 most influential people in D.C., has a long record of working with members of Congress on a bipartisan basis and collaborating with stakeholders across the health care industry. Reilly is a frequent presenter on industry-related issues, including testifying before Congress on multiple occasions.
Reilly has over two decades of experience at PhRMA; prior to her current role, Reilly was the executive vice president of policy, research and membership at PhRMA, leading the development and implementation of legislative, regulatory and political strategies to advance policies that encourage patient access and medical innovation. She has also served as counsel at the U.S. House of Representatives Committee on Commerce and was Counsel to a member of the House Ways and Means Committee.
Reilly received a B.A. in political science from the University of Nebraska-Lincoln where she graduated with honors, and a J.D. from the University of Nebraska College of Law. She currently resides in Alexandria, Virginia with her husband and their four children.
Lori Reilly
https://www.linkedin.com/in/lorireillyphrma/
Chief Operating Officer
New study: HPV vaccination helps prevent cervical cancer deaths
Staffing up: Building the future biopharma workforce to keep America in the lead
Nearly 80 researchers advocate on Capitol Hill
America's cancer research progress is real and worth protecting
The importance of partnership: A conversation with Takeda
Cancer
PhRMA Member Company
The importance of partnership: A conversation with Takeda
The importance of partnership: A conversation with Takeda